CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+14.98%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$787M
AUM Growth
+$787M
(+53%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
29.03%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
459
New
34
Increased
332
Reduced
39
Closed
19
Top Buys
| 1 |
Microsoft
MSFT
|
$18.2M |
| 2 |
NVIDIA
NVDA
|
$11.9M |
| 3 |
Netflix
NFLX
|
$9.94M |
| 4 |
Amazon
AMZN
|
$7.89M |
| 5 |
Meta Platforms (Facebook)
META
|
$7.84M |
Top Sells
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
$3.64M |
| 2 |
Alibaba
BABA
|
$2.59M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$2.4M |
| 4 |
Intel
INTC
|
$2.07M |
| 5 |
Coca-Cola
KO
|
$1.91M |
Sector Composition
| 1 | Technology | 37.36% |
| 2 | Healthcare | 29.98% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Communication Services | 8.97% |
| 5 | Financials | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Replimune Group
REPL
$452M
| $96.5K | 0.01% |
11,808
+4,975
| +73% | +$40.6K |
|
377
Warner Bros
WBD
$28.2B
| $96.1K | 0.01% |
11,004
+6,072
| +123% | +$53K |
|
378
KalVista Pharmaceuticals
KALV
$712M
| $95.2K | 0.01% |
8,024
+4,043
| +102% | +$48K |
|
|
MRNS
379
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $94.5K | 0.01% |
10,458
+4,151
| +66% | +$37.5K |
|
380
iTeos Therapeutics
ITOS
| $93.8K | 0.01% |
6,877
+2,737
| +66% | +$37.3K |
|
381
Adaptive Biotechnologies
ADPT
$1.95B
| $89.5K | 0.01% |
27,896
+11,149
| +67% | +$35.8K |
|
382
Harrow
HROW
$1.4B
| $89.2K | 0.01% |
6,745
+2,682
| +66% | +$35.5K |
|
383
UroGen Pharma
URGN
$887M
| $88.5K | 0.01% |
5,903
+2,328
| +65% | +$34.9K |
|
384
Caribou Biosciences
CRBU
$175M
| $87.5K | 0.01% |
17,024
+6,798
| +66% | +$34.9K |
|
385
Theravance Biopharma
TBPH
$703M
| $86K | 0.01% |
9,583
+3,824
| +66% | +$34.3K |
|
|
WBA
386
DELISTED
Walgreens Boots Alliance
WBA
| $84.4K | 0.01% |
3,890
+2,175
| +127% | +$47.2K |
|
|
RVNC
387
DELISTED
Revance Therapeutics, Inc.
RVNC
| $83.5K | 0.01% |
16,981
+6,826
| +67% | +$33.6K |
|
388
MaxCyte
MXCT
$144M
| $83.3K | 0.01% |
19,884
+7,898
| +66% | +$33.1K |
|
389
Arbutus Biopharma
ABUS
$744M
| $83.2K | 0.01% |
32,233
+12,833
| +66% | +$33.1K |
|
390
Anavex Life Sciences
AVXL
$822M
| $80.3K | 0.01% |
15,773
+6,275
| +66% | +$31.9K |
|
391
Terns Pharmaceuticals
TERN
$652M
| $78K | 0.01% |
11,889
+4,742
| +66% | +$31.1K |
|
392
MeiraGTx Holdings
MGTX
$584M
| $74.3K | 0.01% |
12,246
+4,892
| +67% | +$29.7K |
|
|
THRD
393
DELISTED
Third Harmonic Bio
THRD
| $73.5K | 0.01% |
7,784
+3,119
| +67% | +$29.4K |
|
394
Nautilus Biotechnolgy
NAUT
$84.9M
| $70.8K | 0.01% |
24,076
+9,624
| +67% | +$28.3K |
|
395
Precigen
PGEN
$1.41B
| $69.4K | 0.01% |
47,829
+19,041
| +66% | +$27.6K |
|
396
SiriusXM
SIRI
$7.73B
| $67.2K | 0.01% |
17,332
+9,631
| +125% | +$37.4K |
|
|
AMRN
397
Amarin Corp
AMRN
$315M
| $66.1K | 0.01% |
74,178
+29,579
| +66% | +$26.3K |
|
398
Atea Pharmaceuticals
AVIR
$268M
| $65.4K | 0.01% |
16,179
+6,526
| +68% | +$26.4K |
|
|
DDL
399
Dingdong
DDL
$462M
| $65.3K | 0.01% |
53,514
| – | – |
|
400
ATAI Life Sciences
ATAI
$982M
| $62.8K | 0.01% |
31,899
+12,693
| +66% | +$25K |
|